切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2023, Vol. 17 ›› Issue (05) : 557 -561. doi: 10.3877/cma.j.issn.1674-0785.2023.05.010

临床研究

结直肠癌致腹壁巨大缺损的一期修补经验(附13例报告)
王延召(), 牛鹏飞, 丁长民, 高庆坤, 高兆亚, 安柯, 翟志超, 曾庆敏, 黄文生, 雷福明, 顾晋   
  1. 100144 北京,北京大学首钢医院胃肠外科
  • 收稿日期:2023-01-28 出版日期:2023-05-15
  • 通信作者: 王延召

Primary repair of large abdominal wall defect caused by colorectal cancer: our experience with 13 cases

Yanzhao Wang(), Pengfei Niu, Changmin Ding, Qingkun Gao, Zhaoya Gao, Ke An, Zhichao Zhai, Qingmin Zeng, Wensheng Zeng, Fuming Lei, Jin Gu   

  1. Department of Gastrointestinal Surgery, Peking University Shougang Hospital, Beijing 100144, China
  • Received:2023-01-28 Published:2023-05-15
  • Corresponding author: Yanzhao Wang
引用本文:

王延召, 牛鹏飞, 丁长民, 高庆坤, 高兆亚, 安柯, 翟志超, 曾庆敏, 黄文生, 雷福明, 顾晋. 结直肠癌致腹壁巨大缺损的一期修补经验(附13例报告)[J/OL]. 中华临床医师杂志(电子版), 2023, 17(05): 557-561.

Yanzhao Wang, Pengfei Niu, Changmin Ding, Qingkun Gao, Zhaoya Gao, Ke An, Zhichao Zhai, Qingmin Zeng, Wensheng Zeng, Fuming Lei, Jin Gu. Primary repair of large abdominal wall defect caused by colorectal cancer: our experience with 13 cases[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(05): 557-561.

目的

总结结直肠癌致腹壁巨大缺损一期修补的手术经验。

方法

回顾性分析2012年3月至2021年7月于北京大学首钢医院胃肠外科住院手术治疗的13例(男性10例,女性3例)腹壁受侵犯的原发或复发结直肠癌病例,总结分析其手术修补方式、手术时间、术中出血量、术后恢复时间、术区并发症及随访信息。

结果

腹壁肿瘤的最大直径约为15 cm,切除后的腹壁缺损平均约为15×15 cm2。腹壁组织的缺损修复,采用大腿外侧带蒂肌皮瓣2例,阔筋膜张肌筋膜皮瓣6例,腹壁筋膜皮瓣5例。有8例病例,应用了生物补片修补筋膜及腹膜缺损;2例病例因存在肿瘤部位的感染,采用了一期病灶切除并安装负压引流装置(vacuum sealing drainage,VSD),二期给予皮瓣移植修复。手术时间180~700 min不等,平均为275±36.62 min。术中平均出血量为247.6±22.44 ml。无围手术期死亡病例;1例病人出现皮瓣下脂肪液化;1例病人出现转移皮瓣坏死及感染。手术后留院时间10~34(19.23±5.89)d。术后2例存活不足1年,2例已经存活超过5年。

结论

对于腹壁巨大转移或受累的原发或复发性结直肠癌病例,多学科讨论后认为从技术和及肿瘤学层面可以从手术获益的病例,是否选择手术治疗需要谨慎的从肿瘤学、人文关怀、社会经济学等多个方面进行综合权衡。

Objective

To study the feasibility and rationality of surgical treatment of abdominal wall defect caused by colorectal cancer.

Methods

From March 2012 to July 2021, 13 cases (10 males and 3 females) of primary or recurrent colorectal cancer with large abdominal wall defects after surgery due to abdominal wall involvement were retrospectively analyzed. The age of the patients ranged from 28~78 (52.6±3.87) years old. There were two cases of recurrent or metastatic tumors and one case of primary colon cancer with abdominal wall involvement. The time between recurrence and the first radical operation ranged from 0.5 to 8 years. The surgical repair method, operation time, intraoperative bleeding, postoperative hospital stay time, complications in the operation area, and follow-up information were recorded.

Results

The maximum diameter of abdominal wall tumor was about 15 cm, and the average are of the abdominal wall defects after resection was about 15 cm×15 cm2. The defect of abdominal wall tissue was repaired with the lateral thigh pedicled myocutaneous flap in two cases, the lateral thigh fasciocutaneous flap in six, and the abdominal wall fasciocutaneous flap in five. The biological patch (Cook) was used to repair the defect of the fascia and peritoneum in eight cases. Because of tumor site infection, two cases were treated with a two-step procedure. The lesions were resected and vacuum sealing drainage (VSD) was placed in the first step. And skin flap transplantation was performed after a week of draining. The operation time ranged from 180 to 700 (275±36.62) minutes. The average intraoperative blood loss was (247.6±22.44) ml. The perioperative mortality rate is zero. One patient had subcutaneous fat liquefaction, while another had necrosis and infection of the transferred flap marginal area. All patients were discharged after 10~34 (19.23±5.89) days after operation. Two patients survived for less than 1 year, while another two cases have survived for more than 5 years.

Conclusion

For cases of primary or recurrent colorectal cancer with huge metastasis or involvement of the abdominal wall, after multi-disciplinary discussion, the patients who can benefit from surgery from the aspects of technology and oncology should be carefully weighed from the aspects of oncology, humanistic care, social economics, etc.

表1 病人资料
编号 年龄 性别 腹壁肿瘤大小(cm2 原发病及现在诊断 生物补片 皮瓣类型 出血量(ml) 手术时间(min) 术后留院时间(d) 术后皮瓣并发症 是否2期手术 距离第一次肿瘤复发时间(年) 随访
1 28 15×15 结肠癌复发,肝、结肠、小肠、腹壁受累 阔筋膜张肌筋膜皮瓣 200 255 31 愈合良好 1期切除VSD,2期修复 1 38个月仍存活
2 78 8×7 降结肠癌术后腹腔转移腹壁受累 自体皮肤翻转皮瓣修复筋膜缺损 200 235 19 局部有脂肪液化,经过引流及换药二期愈合 1 7个月仍存活
3 54 15×11 直肠癌术后乙状结肠造口复发 阔筋膜张肌筋膜皮瓣 250 185 16 愈合良好 3 87个月仍存活
4 47 7.5×7 直肠癌术后乙状结肠造口复发 局部腹壁筋膜皮瓣 150 180 12 愈合良好 5 45个月死亡
5 51 10×10 直肠癌术后乙状结肠造口复发 双侧阔筋膜张肌筋膜皮瓣 300 280 34 皮瓣局部坏死 1 6个月死亡
6 32 15×14 直肠癌术后乙状结肠造口复发 局部腹壁筋膜皮瓣 150 200 15 愈合良好 4 12个月死亡
7 48 9.5×7.5 直肠癌术后乙状结肠造口复发 阔筋膜张肌肌皮瓣 200 230 16 愈合良好 2 26个月仍存活
8 54 10×9 直肠癌术后乙状结肠造口复发 大腿带蒂皮瓣 250 ml 285 min 17 愈合良好 3 4个月死亡
9 46 18×9 直肠癌术后乙状结肠造口复发 大腿带蒂皮瓣 300 255 16 愈合良好 1 19个月仍存活
10 68 10×9 直肠癌术后小肠造口复发 阔筋膜张肌筋膜皮瓣 250 250 19 愈合良好 1 12个月仍存活
11 57 13×13 直肠癌术后,造口复发及腹腔转移 局部腹壁筋膜皮瓣 445 700 14 愈合良好 0.5(5个月) 12个月仍存活
12 52 7 结肠癌(溃疡性结肠炎合并结肠癌) 局部腹壁筋膜皮瓣 325 250 10 愈合良好 第一次手术 61个月仍存活
13 70 12 升结肠癌术后腹壁转移瘤 阔筋膜张肌筋膜皮瓣 200 270 31 愈合良好 1期切除VSD,2期修复 8年 38个月死亡
图1 腹部受累切除的典型患者。图a为螺旋CT:肠道肿瘤侵犯腹壁;图b为术前照片:腹壁肿瘤直径约为15 cm;图c为肿瘤切除后;图d为cook补片修补腹膜及筋膜缺损;图e为由于肿瘤感染VSD后拟二期阔筋膜张肌皮瓣修复;图f为2期修补愈合后;图g为局部筋膜皮瓣修复;图h为局部筋膜皮瓣修复修复后;图i为皮瓣并发症局部缺血坏死
1
Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022 [J]. CA Cancer J Clin, 2022, 72(1): 7-33.
2
Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants [J]. Chin Med J (Engl), 2022, 135(5): 584-590.
3
Yang Y, Wang HY, Chen YK, et al. Current status of surgical treatment of rectal cancer in China [J]. Chin Med J (Engl), 2020, 133(22): 2703-2711.
4
Body A, Prenen H, Lam M, et al. Neoadjuvant therapy for locally advanced rectal cancer: Recent advances and ongoing challenges [J]. Clin Colorectal Cancer, 2021, 20(1): 29-41.
5
Tanaka T, Ozawa H, Nakagawa Y, et al. Verifying the M1c category of CRC: analysis of the data from a Japanese multi-institutional database [J]. Int J Colorectal Dis, 2020, 35(1): 125-131.
6
Franko J, Shi Q, Meyers JP, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database [J]. Lancet Oncol, 2016, 17(12): 1709-1719.
7
Ledesma EJ, Tseng M, Mittelman A. Surgical treatment of isolated abdominal wall metastasis in colorectal cancer [J]. Cancer, 1982, 50(9): 1884-1887.
8
Coburn C, Collingridge D. A step towards dignity in life and death [J]. Lancet Oncol, 2018, 19(11): e565.
[1] 袁庆港, 刘理想, 张亮, 周世振, 高波, 丁超, 管文贤. 尿素-肌酐比值(UCR)可预测结直肠癌患者术后的长期预后[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 506-509.
[2] 艾贵生, 杨健, 蒋文涛. 肝移植治疗不可切除结直肠癌肝转移的研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(03): 174-180.
[3] 王苏睿, 胡根, 邵国益. A 型肉毒杆菌毒素在腹腔开放后腹壁缺损修复中的应用[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 649-653.
[4] 陈樽, 王平, 金华, 周美玲, 李青青, 黄永刚. 肌肉减少症预测结直肠癌术后切口疝发生的应用研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 639-644.
[5] 宋华传, 季鹏, 姚焕章, 王永帅, 张珅瑜, 宋瑞鹏, 王继洲. 腹腔镜肝切除术联合微波消融治疗多发性结直肠癌肝转移[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(04): 222-226.
[6] 赵泽云, 李建男, 王旻. 中性粒细胞胞外诱捕网在结直肠癌中的研究进展[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 524-528.
[7] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[8] 张金珠, 梅世文, 孙金峰, 胡刚, 邱文龙, 李国利, 汪欣, 王锡山, 汤坚强. 原发结直肠癌超系膜切除术后患者的生存危险因素分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(03): 197-204.
[9] 顾纪明, 蒋晖, 金留根, 钱程佳, 陈柏, 谢立飞. 腹腔镜辅助结肠次全切除术治疗同时性多原发结直肠癌的应用体会[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(02): 153-157.
[10] 王国强, 张纲, 唐建坡, 张玉国, 杨永江. LINC00839 调节miR-17-5p/WEE1 轴对结直肠癌细胞增殖、凋亡和迁移的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 491-499.
[11] 孙晗, 于冰, 武侠, 周熙朗. 基于循环肿瘤DNA 甲基化的结直肠癌筛查预测模型的构建与验证[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 500-506.
[12] 陈倩倩, 袁晨, 刘基, 尹婷婷. 多层螺旋CT 参数、癌胚抗原、错配修复基因及病理指标对结直肠癌预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 507-511.
[13] 高静, 夏婷婷. 血清乳酸脱氢酶、中性粒细胞/淋巴细胞比值、血浆纤维蛋白原/前白蛋白比值对晚期结直肠癌患者姑息化疗效果与不良反应的评价[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(03): 203-207.
[14] 王湛, 李文坤, 杨奕, 徐芳, 周敏思, 苏珈仪, 王亚丹, 吴静. 炎症指标在早发性结直肠肿瘤中的应用[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 802-810.
[15] 周宁, 尹晓岳, 孙琢玉, 杨学礼, 鲍颖慧, 赵敏, 李伯妍, 刘淼, 谢娟. 腹腔镜与开腹结直肠癌根治术的成本和临床疗效Meta分析[J/OL]. 中华胃肠内镜电子杂志, 2024, 11(02): 105-111.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?